These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 21422210)
41. In vitro susceptibility of amphotericin-B, voriconazole and caspofungin against Candida guilliermondii biofilms, isolated from dentals units water pipes, under different growth phases. Mazari W; Boucherit-Otmani Z; Boucherit K J Mycol Med; 2015 Mar; 25(1):57-62. PubMed ID: 25533329 [TBL] [Abstract][Full Text] [Related]
42. The echinocandins. Cappelletty D; Eiselstein-McKitrick K Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149 [TBL] [Abstract][Full Text] [Related]
43. In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies. Cantón E; Espinel-Ingroff A; Pemán J; del Castillo L Antimicrob Agents Chemother; 2010 May; 54(5):2194-7. PubMed ID: 20145083 [TBL] [Abstract][Full Text] [Related]
44. Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, Sikora M; Kuthan R; Piskorska-Malolepsza K; Golas-Pradzynska M; Domański D; Augustynowicz-Kopeć E; Swoboda-Kopec E Pol J Microbiol; 2019 Sep; 68(3):303-308. PubMed ID: 31880875 [TBL] [Abstract][Full Text] [Related]
45. Characterization of Candida parapsilosis complex isolates. de Toro M; Torres MJ; Maite R; Aznar J Clin Microbiol Infect; 2011 Mar; 17(3):418-24. PubMed ID: 20636431 [TBL] [Abstract][Full Text] [Related]
46. Identification and antifungal susceptibility of Candida species isolated from bloodstream infections in Konya, Turkey. Dagi HT; Findik D; Senkeles C; Arslan U Ann Clin Microbiol Antimicrob; 2016 May; 15(1):36. PubMed ID: 27245756 [TBL] [Abstract][Full Text] [Related]
47. [In vitro activity of amphotericin B and anidulafungin against Candida spp. biofilms]. Valentín A; Cantón E; Pemán J; Quindós G Rev Iberoam Micol; 2007 Dec; 24(4):272-7. PubMed ID: 18095759 [TBL] [Abstract][Full Text] [Related]
48. In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012. Pfaller MA; Castanheira M; Messer SA; Jones RN Mycoses; 2015 Apr; 58(4):209-14. PubMed ID: 25727853 [TBL] [Abstract][Full Text] [Related]
49. Exploring the In Vitro Resistance of Candida parapsilosis to Echinocandins. Chassot F; Venturini TP; Piasentin FB; Rossato L; Fiorini A; Svidzinski TI; Alves SH Mycopathologia; 2016 Oct; 181(9-10):663-70. PubMed ID: 27318852 [TBL] [Abstract][Full Text] [Related]
50. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods. Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252 [TBL] [Abstract][Full Text] [Related]
51. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin. Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656 [TBL] [Abstract][Full Text] [Related]
52. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Najafzadeh MJ; Badali H; Illnait-Zaragozi MT; De Hoog GS; Meis JF Antimicrob Agents Chemother; 2010 Apr; 54(4):1636-8. PubMed ID: 20086140 [TBL] [Abstract][Full Text] [Related]
53. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains. Denardi LB; Keller JT; Oliveira V; Mario DAN; Santurio JM; Alves SH Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006 [TBL] [Abstract][Full Text] [Related]
54. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems. Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279 [TBL] [Abstract][Full Text] [Related]
55. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates. Pfaller MA; Messer SA; Rhomberg PR; Jones RN; Castanheira M J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236 [TBL] [Abstract][Full Text] [Related]
56. [Activity of micafungin against Candida biofilms]. Quindós G; Villar-Vidal M; Eraso E Rev Iberoam Micol; 2009 Mar; 26(1):49-55. PubMed ID: 19463277 [TBL] [Abstract][Full Text] [Related]
57. Susceptibility of Candida albicans biofilms to caspofungin and anidulafungin is not affected by metabolic activity or biomass production. Marcos-Zambrano LJ; Escribano P; Bouza E; Guinea J Med Mycol; 2016 Feb; 54(2):155-61. PubMed ID: 26543157 [TBL] [Abstract][Full Text] [Related]